BBIO

SELL

BridgeBio Pharma, Inc.· Healthcare

Market Cap: $13.2B

Score
5
5

ANDAMENTO PREZZO

$67.74+98.24%

Prezzi aggiornati al 21 ott 2026

INDICATORI TECNICI

RSI (14 giorni)

53Neutro
▪ <30 Ipervenduto (segnale buy)
▪ 30–45 Zona debolezza
▪ 45–55 Neutro
▪ >70 Ipercomprato (attenzione)

MACD (12,26,9)

↑ RialzistaMACD -1.128 · Signal -1.803 · Hist 0.675

Prezzo vs Medie Mobili

SMA 20
$66.26-61.3%
SMA 50
$71.95-64.4%
SMA 200
$72.96-64.9%
Bollinger Band %B0% — Vicino lower band
$64mid $66$68
Volume ratio (vs media 20gg)1.09x

BREAKDOWN SCORE (0 → 100)

P/E Trailing0.0 / 25
FCF Yield0.0 / 25
Price/Book0.0 / 15
EPS0.0 / 15
Debt/Equity5.0 / 10
Dividendo0.0 / 5
Momentum 90gg0.0 / 5

FONDAMENTALI

Clicca i per spiegazione✓ 2 ok~ attenzione✗ 3 negativi
P/E Trailing
—
✗P/E Forward
N/A (perdita)
✓P/B
N/A
✗FCF Yield
-3.4%
✗EPS TTM
-3,57
EPS Q1
—
EPS Growth YoY
—
✓Rev. Growth
120.4%
Debt/Equity
—
Market Cap
$13.2B
Div. Yield
0.0%
Beta
—
52w High
—
52w Low
—
DCF Value
—
Sector
Healthcare

Aggiornato: 22 ott 2026